AdaptHealth [AHCO] vs Enovis [ENOV] Detailed Stock Comparison
AdaptHealth
NASDAQ
Loading...
Enovis
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: AdaptHealth wins in 13 metrics, Enovis wins in 6 metrics, with 0 ties. AdaptHealth appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AdaptHealth | Enovis | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 16.83 | -2.14 | Enovis |
| Price-to-Book Ratio | 0.76 | 0.71 | Enovis |
| Debt-to-Equity Ratio | 122.33 | 56.75 | Enovis |
| PEG Ratio | -0.73 | -0.02 | AdaptHealth |
| EV/EBITDA | 4.89 | 8.97 | AdaptHealth |
| Profit Margin (TTM) | 2.49% | -37.80% | AdaptHealth |
| Operating Margin (TTM) | 7.10% | 2.41% | AdaptHealth |
| EBITDA Margin (TTM) | 7.10% | 2.41% | AdaptHealth |
| Return on Equity | 5.51% | -28.25% | AdaptHealth |
| Return on Assets (TTM) | 3.70% | 0.89% | AdaptHealth |
| Free Cash Flow (TTM) | $235.78M | $-67.21M | AdaptHealth |
| 1-Year Return | -11.20% | -22.28% | AdaptHealth |
| Price-to-Sales Ratio (TTM) | 0.38 | 0.84 | AdaptHealth |
| Enterprise Value | $3.09B | $3.25B | Enovis |
| EV/Revenue Ratio | 0.95 | 1.49 | AdaptHealth |
| Gross Profit Margin (TTM) | -9.11% | 59.29% | Enovis |
| Revenue per Share (TTM) | $24 | $39 | Enovis |
| Earnings per Share (Diluted) | $0.54 | $-14.95 | AdaptHealth |
| Beta (Stock Volatility) | 1.62 | 1.80 | AdaptHealth |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
AdaptHealth vs Enovis Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AdaptHealth | -1.43% | 3.23% | -4.88% | -3.14% | -6.28% | -7.63% |
| Enovis | -2.37% | 3.58% | -0.45% | -5.33% | -3.82% | -29.44% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AdaptHealth | -11.20% | -56.65% | -68.16% | -7.63% | -7.63% | -7.63% |
| Enovis | -22.28% | -30.50% | -42.68% | -35.29% | 15.31% | -11.39% |
News Based Sentiment: AdaptHealth vs Enovis
AdaptHealth
News based Sentiment: MIXED
The month of October 2025 saw a surge in institutional investment in AdaptHealth, indicating growing confidence from major players. However, this positive trend is offset by an insider sale and conflicting analyst ratings, creating a mixed investment narrative. The overall significance is high due to the substantial capital inflows.
Enovis
News based Sentiment: POSITIVE
October was a notably positive month for Enovis, marked by significant analyst upgrades, substantial insider buying activity, and a clear strategic direction under its new CEO. These developments suggest growing confidence in the company's future prospects and potential for growth, making it a significant month for investors.
Performance & Financial Health Analysis: AdaptHealth vs Enovis
| Metric | AHCO | ENOV |
|---|---|---|
| Market Information | ||
| Market Cap | $1.26B | $1.83B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 914,870 | 615,380 |
| 90 Day Avg. Volume | 1,022,170 | 899,257 |
| Last Close | $8.96 | $31.26 |
| 52 Week Range | $7.11 - $11.63 | $25.47 - $49.83 |
| % from 52W High | -22.96% | -37.27% |
| All-Time High | $41.58 (Feb 01, 2021) | $129.72 (Jun 09, 2014) |
| % from All-Time High | -78.45% | -75.90% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.01% | 0.08% |
| Quarterly Earnings Growth | -0.25% | 0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.38% |
| Operating Margin (TTM) | 0.07% | 0.02% |
| Return on Equity (TTM) | 0.06% | -0.28% |
| Debt to Equity (MRQ) | 122.33 | 56.75 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $12.00 | $45.11 |
| Cash per Share (MRQ) | $0.53 | $0.77 |
| Operating Cash Flow (TTM) | $552.34M | $188.06M |
| Levered Free Cash Flow (TTM) | $235.10M | $65.68M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: AdaptHealth vs Enovis
| Metric | AHCO | ENOV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 16.83 | -2.14 |
| Forward P/E | 10.69 | 10.13 |
| PEG Ratio | -0.73 | -0.02 |
| Price to Sales (TTM) | 0.38 | 0.84 |
| Price to Book (MRQ) | 0.76 | 0.71 |
| Market Capitalization | ||
| Market Capitalization | $1.26B | $1.83B |
| Enterprise Value | $3.09B | $3.25B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.95 | 1.49 |
| Enterprise to EBITDA | 4.89 | 8.97 |
| Risk & Other Metrics | ||
| Beta | 1.62 | 1.80 |
| Book Value per Share (MRQ) | $12.00 | $45.11 |
Financial Statements Comparison: AdaptHealth vs Enovis
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AHCO | ENOV |
|---|---|---|
| Revenue/Sales | $580.47M | $564.55M |
| Cost of Goods Sold | $657.44M | $229.85M |
| Gross Profit | $-76.97M | $334.70M |
| Research & Development | N/A | $30.70M |
| Operating Income (EBIT) | $23.17M | $-16.08M |
| EBITDA | $117.52M | $55.91M |
| Pre-Tax Income | $-5.23M | $-25.65M |
| Income Tax | $850,000 | $10.80M |
| Net Income (Profit) | $-6.08M | $-36.55M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AHCO | ENOV |
|---|---|---|
| Cash & Equivalents | $53.65M | $38.46M |
| Total Current Assets | $745.17M | $1.22B |
| Total Current Liabilities | $576.73M | $477.42M |
| Long-Term Debt | $2.04B | $1.42B |
| Total Shareholders Equity | $1.57B | $2.62B |
| Retained Earnings | $-569.39M | $-338.99M |
| Property, Plant & Equipment | $1.03B | $492.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AHCO | ENOV |
|---|---|---|
| Operating Cash Flow | $95.33M | $-1.07M |
| Capital Expenditures | $-95.59M | $-43.26M |
| Free Cash Flow | $-58,000 | $-44.86M |
| Debt Repayment | $-28.22M | $-15.44M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AHCO | ENOV |
|---|---|---|
| Shares Short | 10.40M | 6.93M |
| Short Ratio | 11.51 | 7.31 |
| Short % of Float | 0.10% | 0.18% |
| Average Daily Volume (10 Day) | 914,870 | 615,380 |
| Average Daily Volume (90 Day) | 1,022,170 | 899,257 |
| Shares Outstanding | 134.60M | 55.88M |
| Float Shares | 89.45M | 56.42M |
| % Held by Insiders | 0.08% | 0.02% |
| % Held by Institutions | 1.04% | 1.21% |
Dividend Analysis & Yield Comparison: AdaptHealth vs Enovis
| Metric | AHCO | ENOV |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |